Efficacy and Safety of Different Doses of Indacaterol

Exclusion Criteria

• •Smoking history \>10 pack-years
• •Patients with a diagnosis of chronic obstructive pulmonary disease (COPD)
• •Patients with seasonal allergy whose asthma is likely to deteriorate during the study period
• •Patients who have experienced a severe asthma attack/exacerbation requiring hospitalization in the 6 months prior to screening
• •Patients who have had an intubation for a severe asthma exacerbation
• •Patients who have had an emergency room visit for an asthma attack/asthma exacerbation within 6 weeks prior to screening
• •Patients who have had a respiratory tract infection within 6 weeks prior to screening
• •Patients with concomitant pulmonary disease
• •Patients with diabetes Type I or uncontrolled diabetes Type II
• •Any patient with lung cancer or a history of lung cancer
• •Patients with a history of certain cardiovascular comorbid conditions
• •Patients who have ever received or are currently receiving omalizumab or chronic oral corticosteroid therapy